These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 21052020

  • 1. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
    Rhaleb NE, Pokharel S, Sharma U, Carretero OA.
    J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM, Ling YH, Huuskes BM, Ferens DM, Saini N, Chan CT, Diep H, Kett MM, Samuel CS, Kemp-Harper BK, Robertson AAB, Cooper MA, Peter K, Latz E, Mansell AS, Sobey CG, Drummond GR, Vinh A.
    Cardiovasc Res; 2019 Mar 15; 115(4):776-787. PubMed ID: 30357309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.
    Sharma U, Rhaleb NE, Pokharel S, Harding P, Rasoul S, Peng H, Carretero OA.
    Am J Physiol Heart Circ Physiol; 2008 Mar 15; 294(3):H1226-32. PubMed ID: 18178715
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B, Wang W, Ji XY, Ritter JK, Li N.
    BMC Nephrol; 2020 May 11; 21(1):173. PubMed ID: 32393187
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
    Castoldi G, di Gioia CR, Bombardi C, Preziuso C, Leopizzi M, Maestroni S, Corradi B, Zerbini G, Stella A.
    Am J Nephrol; 2013 May 11; 37(1):65-73. PubMed ID: 23327833
    [Abstract] [Full Text] [Related]

  • 14. Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
    Rasoul S, Carretero OA, Peng H, Cavasin MA, Zhuo J, Sanchez-Mendoza A, Brigstock DR, Rhaleb NE.
    J Hypertens; 2004 Mar 11; 22(3):593-603. PubMed ID: 15076166
    [Abstract] [Full Text] [Related]

  • 15. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
    Quigley JE, Elmarakby AA, Knight SF, Manhiani MM, Stepp DW, Olearzcyk JJ, Imig JD.
    Clin Exp Pharmacol Physiol; 2009 Jul 11; 36(7):724-8. PubMed ID: 19207724
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
    Wang Y, Wang DH.
    Mol Med; 2011 Jul 11; 17(11-12):1204-12. PubMed ID: 21792478
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
    Zhang J, Zhu M, Zhang S, Xie S, Gao Y, Wang Y.
    Int Immunopharmacol; 2020 Dec 11; 89(Pt A):107035. PubMed ID: 33045566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.